AI-driven drug discovery
-
Business & Markets · Startups TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery
Insider Brief PRESS RELEASE — TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round… -
Business & Markets · Startups Tevogen Receives $1M to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
-
Technology & Infrastructure · Models & LLMs AI-Driven Drug Discovery Company Insilico Medicine and UAE University Sign MoU to Develop Talent and Academic Innovation
-
Business & Markets · Enterprise Pfizer Expands AI-Driven Drug Discovery Partnership with Data4Cure
-
Business & Markets · Startups AQEMIA Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.